Garth A. Beinart, M.D.
Internal Medicine Residency, University of California at San Francisco, San Francisco, CA
Dr. Beinart earned numerous honors during his medical education and postdoctoral training, including the Caplovitz Award for Outstanding Senior Student in Internal Medicine, the Baylor Alumni Award, membership in the Alpha Omega Alpha honor society, and a MERIT Award for research from the American Society of Clinical Oncology (ASCO) Foundation. He assumed his positions at Methodist in 2007.
Dr. Beinart´s research involves clinical trials of investigational new drugs and gene therapy for the treatment of various types of cancers, including pancreatic, breast, prostate, and lung.
Cancer, clinical trials, chemotherapy.
Li D, Li Y, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Effects of base excision repair gene polymorphisms on pancreatic cancer survival. Int J Cancer. 2007;120(8):1748-1754.
Beinart GA, Gonzalez-Angulo AM, Broglio K, Frye D, Walters R, Holmes FA, Gunale S, Booser D, Rosenthal J, Dhingra K, Young JA, Hortobagyi GN. Phase II trial of 10-EDAM in the treatment of metastatic breast cancer. Cancer Chemother Pharmacol. 2007;60(1):61-67.
Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res. 2006;66(6):3323-3330.
Beinart G, Rini BI, Weinberg V, Small EJ. Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer. Clin Prostate Cancer. 2005;4(1):55-60.
Beinart G, Damon L. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia. Am J Hematol. 2004;77(4):331-335.